Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
serine/threonine kinase 31 | 0.751 | 0.231 | 6.6E-03 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
tau tubulin kinase 2 | 0.682 | 0.423 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
protein O-mannose kinase | 0.590 | 0.500 | 1.9E-08 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
titin | 0.470 | 0.885 | 2.6E-96 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
EPH receptor B3 | 0.682 | 0.462 | 0.46 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
TAO kinase 3 | 0.792 | 0.269 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
FER tyrosine kinase | 0.628 | 0.615 | 0.66 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
p21 (RAC1) activated kinase 6 | 0.729 | 0.385 | 4.3E-05 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
DM1 protein kinase | 0.603 | 0.692 | 3.8E-02 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 41 | 0 | 1985 | 2019 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 1985 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
gastrin releasing peptide | 0.524 | 0.769 | 2.5E-03 |
|
disease | 0.100 | None | 1.000 | 36 | 0 | 1986 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1986 | 2017 | ||||||||
|
enolase 2 | 0.475 | 0.846 | 0.38 |
|
disease | 0.100 | None | 1.000 | 31 | 0 | 1987 | 2019 | ||||||||
|
small cell cancer of the lung | 0.612 | 0.577 |
|
disease | 0.100 | None | 0.944 | 18 | 0 | 1987 | 2019 | |||||||||
|
MYCL proto-oncogene, bHLH transcription factor | 0.599 | 0.731 | 0.12 |
|
disease | 0.400 | None | 1.000 | 17 | 0 | 1987 | 2017 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
disease | 0.390 | None | 1.000 | 10 | 0 | 1987 | 2017 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1987 | 2019 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1987 | 2002 | ||||||||
|
pregnancy specific beta-1-glycoprotein 2 | 0.492 | 0.731 | 1.4E-30 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1987 | 2019 | ||||||||
|
dopa decarboxylase | 0.535 | 0.769 | 3.8E-08 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 1987 | 2020 | ||||||||
|
CEA cell adhesion molecule 3 | 0.494 | 0.731 | 1.1E-09 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1987 | 2019 | ||||||||
|
CEA cell adhesion molecule 7 | 0.494 | 0.769 | 1.3E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1987 | 2019 |